Type Size
Clinical Trials
PYR-210: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 2b Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Patients with Nephropathy Due to Type 2 Diabetes
IRB-HSR# 13884
Service:
Diabetes & Metabolism,
Kidney
|
Category: Endocrinology, Nephrology (Kidney)
Adult Enrollment: Yes
|
Minor Enrollment: No
Primary Investigator: Bolton W. Kline, M.D.
Contact Information
Contact: Cindi Peterson
Phone: (434)924-5820
E-mail: cmp3c@virginia.edu
Clinical Trial Description
Have you developed kidney disease related to your diabetes?
Men and Women, age 25 and over, with type 2 diabetes mellitus may be eligible to participate in a research study to test an investigational medication.
Qualified participants will receive at no cost:
- Study-related medication
- Study-related physical exam
- Study-related lab testing
